Palvella Therapeutics (PVLA) Revenue Growth (1y) (2015 - 2024)
Palvella Therapeutics (PVLA) Revenue Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Palvella Therapeutics | 1.88 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -97.36% |
| Dec 31, 2023 | -2,143.80% |
| Sep 30, 2023 | 7,465.89% |
| Jun 30, 2023 | 8,619.57% |
| Mar 31, 2023 | -81.71% |
| Dec 31, 2022 | -98.38% |
| Sep 30, 2022 | -93.64% |
| Jun 30, 2022 | -69.13% |
| Mar 31, 2022 | -15.48% |
| Dec 31, 2021 | 338.84% |
| Sep 30, 2021 | 57.37% |
| Jun 30, 2021 | -93.18% |
| Mar 31, 2021 | -1.97% |
| Dec 31, 2020 | -120.47% |
| Sep 30, 2020 | -82.96% |
| Jun 30, 2020 | 104.99% |
| Mar 31, 2020 | 55.19% |
| Dec 31, 2019 | 2,778.33% |
| Sep 30, 2019 | 81.33% |
| Jun 30, 2019 | -54.39% |